Font Size

SCREEN

Profile

Direction

Menu Style

 
FINAL website banner 
 
    

OPTIONS X Pre-conference Workshop

Health Technology Assessment for Vaccines

Date:     28 August 
Time:    8.30am-2pm
Venue:  National University of Singapore
              Seminar room 1 (Level 8)
                Tahir Foundation Building (MD1)
                12 Science Drive 2
                Singapore 117549

Cost:     Full rate SGD $325     Student rate SGD $225 

REGISTRATION

OPTIONS X delegates can add this workshop during online registration OR if already registered, can login to their ISIRV account here and choose 'add events' in the Conferences section.

Others who wish to attend this workshop can register here


About the course -

As more low and middle-income countries (LMICs) commit themselves to achieving Universal Health Coverage (UHC), it is timely to understand the current policy environment and implementation aspects of immunization programs as they relate to UHC policies in the LMICs.

This Health Technology Assessment (HTA) workshop aims to provide knowledge on the use of HTA methods and processes for policy development to support universal access to vaccinations and their contribution to UHC policies. This forum will serve as a platform for technical and policy exchange among stakeholders from both public and private sectors, and to learn from experienced experts working in universities, governments and World Health Organization.

This workshop is aimed at participants who are members of NITAGs, HTA agencies, Ministries of Health, EPI managers and others making decisions about vaccine introduction.

Draft Programme


        

INSTRUCTORS:

Mark Jit 
London School of Hygiene & Tropical Medicine (LSHTM)
 
Joe Wu
Hong Kong University (HKU)
 
Yot Teerawattananon
NUS & HITAP
 
Wanrudee Isaranuwatchai
HITAP & University of Toronto
 
Saudamini Dabak
HITAP
 
Kiesha Prem
London School of Hygiene & Tropical Medicine (LSHTM)

8.15-8.45

REGISTRATION     (tea & coffee provided)
8.45-9.30
SESSION 1:
HTA 101 Understanding Health Technology Assessment in 30 Minutes
 
9.30-10.45    
SESSION 2:
Vaccine Introduction in the Era of Universal Health Coverage - the Role of HTA  evidence and process
 
10.45-11.00
Refreshment Break

11.00-12.00

SESSION 3:
Panel Discussion on Country Experience Of Using HTA to Support Vaccine Introduction  And Price Negotiation (Bhutan, Thailand + representative African community)
 
12.00-12.45 Lunch Break
12.45-13.30
SESSION 4:
Identifying and Using HTA Evidence from International Sources for Vaccine Introduction and Evaluation at Country Level
 
13.30-14.00
SESSION 5:
HTA for Vaccine R&D (Early HTA)